Cargando…

AMIGO2 attenuates innate cisplatin sensitivity by suppression of GSDME‐conferred pyroptosis in non‐small cell lung cancer

Non‐small cell lung cancer (NSCLC) accounts for approximately 85% of lung cancer. Cisplatin is commonly used in the treatment of many malignant tumours including NSCLC. The innate drug sensitivity greatly affects the clinical efficacy of cisplatin‐based chemotherapy. As a plasma membrane adhesion mo...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Lian‐kuai, Lin, Shu‐ping, Xie, Yong‐huan, Tan, Xiang‐peng, Xiong, Ben‐han, Zeng, Xiang‐feng, Zhu, Cai‐rong, Cao, Shao‐yi, Ye, Xiao‐yan, Liu, Hong‐jiao, Wu, Xiao‐ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10424296/
https://www.ncbi.nlm.nih.gov/pubmed/37438979
http://dx.doi.org/10.1111/jcmm.17827